Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

920 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis.
Bhattacharya SK, Sinha PK, Sundar S, Thakur CP, Jha TK, Pandey K, Das VR, Kumar N, Lal C, Verma N, Singh VP, Ranjan A, Verma RB, Anders G, Sindermann H, Ganguly NK. Bhattacharya SK, et al. Among authors: sundar s. J Infect Dis. 2007 Aug 15;196(4):591-8. doi: 10.1086/519690. Epub 2007 Jun 29. J Infect Dis. 2007. PMID: 17624846 Clinical Trial.
Paromomycin in the treatment of leishmaniasis.
Sundar S, Chakravarty J. Sundar S, et al. Expert Opin Investig Drugs. 2008 May;17(5):787-94. doi: 10.1517/13543784.17.5.787. Expert Opin Investig Drugs. 2008. PMID: 18447603 Review.
Oral treatment of visceral leishmaniasis with miltefosine.
Sundar S, Gupta LB, Makharia MK, Singh MK, Voss A, Rosenkaimer F, Engel J, Murray HW. Sundar S, et al. Ann Trop Med Parasitol. 1999 Sep;93(6):589-97. doi: 10.1080/00034989958096. Ann Trop Med Parasitol. 1999. PMID: 10707104 Clinical Trial.
920 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page